Mini-CHOP and Rituximab in Patients Aged Over 80 Years
The purpose of the study is to evaluate efficacy and safety of R-miniCHOP for elderly patients with diffuse large B-Cell lymphoma (DLBC) Lymphoma aged over 80 years by measuring the overall survival.
Diffuse Large B-Cell Lymphoma
DRUG: R mini CHOP
Evaluating efficacy of R-miniCHOP by overall survival, 2 years overall survival
Evaluating R-miniCHOP efficacy by Event free survival, 2 years event free survival
The purpose of the study is to evaluate efficacy and safety of R-miniCHOP for elderly patients with diffuse large B-Cell lymphoma (DLBC) Lymphoma aged over 80 years by measuring the overall survival.